KLK3 and metastatic neoplasm: Although we analyzed the components of MACE separately and matched the cohort on several cardiovascular baseline comorbidities, the presence of metastatic disease, and PSA levels, we could not account for all characteristics, and PSA data were not available for approximately two-thirds of patients.